Angelica sinensis root extract

Drug Overview

Angelica sinensis root extract, commonly known as Dong Quai or Danggui, is a botanical preparation derived from the dried root of the Angelica sinensis plant, a member of the Apiaceae family. Historically dubbed “Female Ginseng” due to its extensive use in traditional Chinese medicine (TCM) for gynecological ailments, it is now being intensely investigated as a supportive agent in oncology.

While it is not an FDA-approved “drug” for the cure of cancer, its complex chemical profile—rich in polysaccharides, phthalides, and organic acids—has led to its use in integrated treatment plans. It is primarily utilized to manage the side effects of chemotherapy and radiation, such as anemia, fatigue, and tissue inflammation.

• Generic Name: Angelica sinensis root extract.
• Common Names: Dong Quai, Danggui, Chinese Angelica, Female Ginseng.
• Drug Class: Botanical / Dietary Supplement / Biological Response Modifier.
• Route of Administration: Oral (capsules, tablets, liquid extracts, or decocted teas).
• FDA Approval Status: Investigational/Dietary Supplement. In the United States, it is regulated as a supplement and is not approved as a primary treatment for any malignancy.

What Is It and How Does It Work? (Mechanism of Action)

he therapeutic potential of Angelica sinensis is attributed to its multifaceted bioactive components, most notably Angelica sinensis polysaccharides (ASP), Z-ligustilide, and ferulic acid. These molecules interact with several biological pathways involved in cell survival and tissue recovery.

Molecular Level Mechanisms

1. Induction of Apoptosis: Research (updated through 2025) indicates that extracts of Angelica sinensis can trigger apoptosis (programmed cell death) in aggressive tumor lines, including glioblastoma multiforme and colorectal cancer. This occurs through both $p53$-dependent and $p53$-independent pathways, effectively “forcing” cancer cells to self-destruct.
2. Hematopoietic Stimulation: One of its most valued roles in oncology is the stimulation of blood cell production. It activates macrophages and enhances the proliferation of bone marrow cells, which helps counter the bone marrow suppression (myelosuppression) often caused by chemotherapy agents like 5-fluorouracil.
3. Anti-Angiogenic Activity: Components like butylidenephthalide have been shown to inhibit the formation of new blood vessels (angiogenesis). By cutting off the “nutrient pipelines” to a tumor, the extract helps starve the cancer and prevent it from expanding.
4. Selective Cytotoxicity: Laboratory studies (2024) have demonstrated that the extract is significantly more toxic to cancer cells (such as MCF-7 breast cancer and CaSki cervical cancer cells) than to normal healthy fibroblasts, suggesting a level of target-specific action.
5. Free Radical Scavenging: Its ferulic acid content acts as a potent antioxidant, neutralizing reactive oxygen species (ROS). This provides a “radioprotective” effect, shielding healthy lung and skin tissue from the oxidative damage caused by radiation therapy.

FDA-Approved Clinical Indications

Currently, Angelica sinensis does not hold FDA-approved indications for cancer treatment. However, it is a primary component of evidence-based integrative protocols and TCM for:

Supportive Oncology (Investigational):

• Radiation-Induced Dermatitis: Used topically or systemically to reduce the severity of skin inflammation in breast cancer patients undergoing radiation.
• Cancer-Related Anemia: Used to support red blood cell recovery in patients experiencing chemotherapy-induced blood loss.
• Hormone-Suppression Side Effects: Investigated for the management of hot flashes and night sweats in patients receiving endocrine therapy, though clinical results for this specific use remain mixed.

Non-oncological Uses:

• Gynecological Disorders: Management of menstrual irregularities, dysmenorrhea, and menopausal symptoms.
• Cardiovascular Support: Used to improve microcirculation and protect against ischemic damage in the heart and brain.

Dosage and Administration Protocols

Because Angelica sinensis is a botanical product, dosages are typically based on the concentration of specific markers (like ferulic acid) or the traditional preparation of the raw root.

Clinical Efficacy and Research Results

Recent meta-analyses and population studies (2020–2026) have clarified the safety and efficacy of this extract in cancer populations.

• Endometrial Cancer Meta-analysis (2025): A comprehensive study involving nearly 900 samples found that adding Angelica sinensis to standard chemotherapy protocols significantly improved the Quality of Life (QoL) scores and TCM symptom scores in patients with endometrial cancer.
• Breast Cancer Safety Data: A large-scale population-based study suggested that Angelica sinensis exposure was associated with a weakly protective effect against breast cancer. Contrary to previous fears that its phytoestrogens might stimulate tumors, current evidence implies it can be safely prescribed in appropriate doses under oncological supervision.
• Prevention of Recurrence: In patients treated with Tamoxifen, those who used Angelica sinensis-containing formulas showed a lower risk of subsequent endometrial cancer compared to those who did not, suggesting it may counteract some of the negative side effects of specific cancer drugs.

Safety Profile and Side Effects

While generally considered low-toxicity, the use of Angelica sinensis requires caution due to its effects on blood clotting and hormone levels.

Common Side Effects (>10%):

• Photosensitivity: Significant increase in skin sensitivity to UV light, leading to a higher risk of severe sunburn or dermatitis.
• Gastrointestinal Upset: Bloating, gas, and occasional diarrhea.
• Loss of Appetite: Sometimes reported with long-term use.

Serious Adverse Events & Precautions:

• Bleeding Risk: The coumarin derivatives in the root can have an additive effect with anticoagulants. This may lead to an increased risk of bruising or internal bleeding.
• Hormone-Sensitive Cancers: Because it may exert weak estrogenic activity, it should be used with extreme caution (or avoided) in patients with active, hormone-receptor-positive (ER+) cancers unless managed by an integrative oncologist.
• Pregnancy/Breastfeeding: Generally considered unsafe; it can stimulate uterine contractions and affect fetal development.

Critical Warning: Stop taking Angelica sinensis at least 2 weeks prior to any scheduled surgery to prevent excessive bleeding during or after the procedure.

Research Areas

A major current focus in Regenerative Medicine is the effect of Angelica sinensis polysaccharides (ASP) on Mesenchymal Stem Cells (MSCs). Recent studies (2022–2024) show that ASP can promote the differentiation of bone marrow stem cells into healthy bone cells while inhibiting their transformation into fat cells. This has profound implications for treating cancer-related osteoporosis and bone loss caused by long-term hormone therapy.

Additionally, researchers are exploring “Combined Regenerative Therapy,” where Angelica sinensis is used alongside stem cell transplants to enhance the “homing” of the new cells to damaged tissues in the brain after a stroke or radiation-induced injury.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed:

• Coagulation Profile (PT/INR): Essential if the patient is taking Warfarin or other blood thinners.
• Hormone Receptor Status: To assess risk in patients with breast or uterine cancers.
• Baseline CBC: To track the extract’s effect on blood cell recovery.

Precautions During Treatment:

• Sun Protection: Patients must use high-SPF (30+) sunscreen and wear protective clothing to prevent phototoxic reactions.
• Interaction Awareness: It interacts significantly with Warfarin, Heparin, and NSAIDs (like Ibuprofen), which can spike the risk of bleeding.

“Do’s and Don’ts” List:

• DO notify your oncology team if you experience unexplained bruising or prolonged bleeding from small cuts.
• DO source your extract from reputable pharmacies that provide standardized “Danggui” to avoid contamination with toxic “Water Hemlock.”
• DON’T use high doses for longer than 6 months, as the safety of chronic exposure to its coumarin content is not yet fully established.
• DON’T take Dong Quai during the first trimester of pregnancy due to its potential for uterine stimulation.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. Angelica sinensis root extract is a botanical supplement and should not replace conventional cancer treatments prescribed by your physician. Some components of this herb may interfere with the efficacy of certain chemotherapies or hormone therapies. Always consult with a qualified oncologist or integrative medicine specialist before beginning any herbal regimen.